Santarus Tries To Shoot Down Zydus' Generic Zegerid

Law360, Los Angeles (December 23, 2011, 2:06 PM EST) -- Santarus Inc. and the University of Missouri on Wednesday struck Zydus Pharmaceuticals USA Inc. with a patent infringement suit in New Jersey federal court, continuing an ongoing fight to block generic versions of the heartburn drug Zegerid.

The lawsuit was launched in response to Zydus filing an abbreviated new drug application with the U.S. Food and Drug Administration regarding its intent to market a generic version of the drug before Santarus' patents expire. Zydus notified Santarus in November that it was seeking approval to market a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.